Vanguard Group Inc Bioventus Inc. Transaction History
Vanguard Group Inc
- $5.12 Trillion
- Q2 2024
A detailed history of Vanguard Group Inc transactions in Bioventus Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 1,660,666 shares of BVS stock, worth $22.1 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,660,666
Previous 1,218,500
36.29%
Holding current value
$22.1 Million
Previous $6.34 Million
50.69%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding BVS
# of Institutions
113Shares Held
39.9MCall Options Held
138KPut Options Held
137K-
Essex Woodlands Management, Inc. The Woodlands, TX13MShares$173 Million24.48% of portfolio
-
Juniper Investment Company, LLC New York, NY6.83MShares$91 Million18.67% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT5.34MShares$71.1 Million2.05% of portfolio
-
Black Rock Inc. New York, NY2.37MShares$31.6 Million0.0% of portfolio
-
Sv Health Investors, LLC Boston, MA1.49MShares$19.8 Million32.28% of portfolio
About Bioventus Inc.
- Ticker BVS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 61,664,200
- Market Cap $821M
- Description
- Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral ner...